A. Consumable
hemp products must bear labeling that includes a scannable bar code, QR code,
or a web address linked to a document or website containing the certificate of
analysis for that product.
B. The
certificate of analysis must be from a laboratory that is accredited by the
Louisiana Department of Health, Office of Public Health (LDH/OPH).
Accreditation will be demonstrated by the availability of a current audit from
a third-party entity indicating that the laboratory meets the criteria
specified in Standard 17025 of the accrediting body.
C. The certificate of analysis must include,
at a minimum, the following information:
1.
the batch number of the product;
2.
the date the batch was received by the laboratory;
3. the date the testing was
completed;
4. the laboratory
methodology used for each analysis referenced in the report;
5. a cannabinoid profile listing all major
phytocannabinoid constituents by percentage of dry weight;
6. serving size for the product, total THC
(as defined in
R.S.
3:1481) per serving, number of servings per
package, and total THC per package (expressed in terms of milligrams per
gram);
7. the amount of any
detected residual solvent in the product in the product in parts per million,
except that this analyte will not be required for floral hemp material;
detections may not meet or exceed the following amounts:
a. butanes-800 ppm;
b. heptanes-500 ppm;
c. benzene-1 ppm;
d. toluene-1 ppm;
e. hexanes-10 ppm;
f. xylenes-1 ppm;
g. ethanol-5,000 ppm; this ethanol limit
shall not apply to consumable hemp products designed and intended solely for
topical use;
8. the
amount of any detected pesticide residues in the product in parts per million;
any detection above the limit of quantitation for a category I pesticide (see
Table 1 of this Section) is defined as an exceedance and a basis for rejection
of the product by the department; category II pesticides have maximum
contaminant levels as defined in Table 1;
9. the amount of any microbiological
contaminants in the product in appropriate units; total yeast/mold may not meet
or exceed 10,000 colony-forming units per gram and total pathogenic
Escherichia coli bacteria or Salmonella spp.
may not meet or exceed 1 colony-forming unit per gram;
10. the amount of any detected heavy metal
traces in the product in parts per million; detections may not meet or exceed
the following amounts:
a. arsenic (As)-10
ppm;
b. cadmium (Cd)-4.1
ppm;
c. lead (Pb)-10 ppm;
d. mercury (Hg)-2 ppm.
11. a cannabinoid profile for the
"active ingredient" (cannabinoid-containing distillate or isolate used in
formulating the finished product) listing all major cannabinoid constituents by
percentage of dry weight.
D.
Repealed.
E. Table 1: Category I
and II Pesticides
|
Name
|
Maximum Contaminant Level (MCL) in
ppm
|
|
Category I (includes aldicarb, carbofuran,
chlorpyrifos, coumaphos, daminozide, dichloryos, dimethoate, ethoprop(hos),
etofenprox, fenoxycarb, imazalil, methocarb, methyl parathion, meyinphos,
paclobutrazol, propoxur, spiroxamine, and thiacloprid)
|
0
|
|
Category II
|
|
|
Abamectin
|
0.3
|
|
Acephate
|
5
|
|
Acetamiprid
|
5
|
|
Acequinocyl
|
4
|
|
Azoxystrobin
|
40
|
|
Bifenazate
|
5
|
|
Bifenthrin
|
0.5
|
|
Boscalid
|
10
|
|
Captan
|
5
|
|
Carbaryl
|
0.5
|
|
Chlorantraniliprole
|
40
|
|
Clofentezine
|
0.5
|
|
Cyfluthrin
|
1
|
|
Cypermethrin
|
1
|
|
Diazinon
|
0.2
|
|
Dimethomorph
|
20
|
|
Etoxazole
|
1.5
|
|
Fenhexamid
|
10
|
|
Fenpyroximate
|
2
|
|
Flonicamid
|
2
|
|
Hexythiazox
|
2
|
|
Fludioxionil
|
30
|
|
Imidacloprid
|
3
|
|
Kresoxim-methyl
|
1
|
|
Malathion
|
5
|
|
Metalaxyl
|
15
|
|
Methomyl
|
0.1
|
|
Myclobutanil
|
9
|
|
Naled
|
0.5
|
|
Oxamyl
|
0.2
|
|
Pentachloronitrobenzene
|
0.2
|
|
Permethrin
|
20
|
|
Phosmet
|
0.2
|
|
Piperonylbutoxide
|
8
|
|
Prallethrin
|
0.4
|
|
Propiconazole
|
20
|
|
Pyrethrins
|
1
|
|
Pyradiben
|
3
|
|
Spinetoram
|
3
|
|
Spinosad
|
3
|
|
Spiromesifen
|
12
|
|
Spirotetramat
|
13
|
|
Tebuconazole
|
2
|
|
Thiamethoxam
|
4.5
|
|
Trifloxystrobin
|
30
|
Notes
La.
PUBLIC HEALTH-FOOD, DRUGS, AND COSMETICS
§
I-519
Promulgated
by the Department of Health, Office of Public Health,
LR
46359 (3/1/2020), Amended
LR
47480 (4/1/2021), Amended
LR
481291 (5/1/2022), Amended
LR
482982 (12/1/2022), Amended
LR
50407 (3/1/2024), Amended
LR
51 (EMERGENCY).
AUTHORITY NOTE:
Promulgated in accordance with
R.S.
40:4(A)(13),
R.S.
3:1483(L) and
R.S.
40:604.